SEC Form 4 · accession 0001209191-18-009399
Travere Therapeutics, Inc. · TVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Clague
Officer — Chief Financial Officer
Period of report
Feb 8, 2018
Accepted (ET)
Feb 12, 2018 · 8:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 8, 2018 | A | 2,033 | $0.00 | A | 2,033 | D |
Table II — derivative securities
No Table II lines on this filing.